The study, led by Hideaki Bando from National Cancer Center Hospital East, Chiba, Japan, was presented at the ASCO Gastrointestinal…
Browsing: Clinical Updates
Dr. Dana Lukin, MD, AGAF, from Weill Cornell Medical College, praised the method for its potential in confirming IBD diagnoses…
The study evaluated the effectiveness of a treatment regimen combining pembrolizumab (an immune checkpoint inhibitor) with chemotherapy in patients with…
The study involved 9,631 adults aged 35–65 years and analyzed various factors like demographic characteristics, behavioral habits, nutritional intake, physical…
A presenter at the Crohn’s & Colitis Congress outlined some of the newer therapies that have expanded the current “arsenal…
A previously unknown type of replicating agent named “obelisks” has been found in genomic data from stool samples – but…
An initiative at the University of North Carolina health system successfully increased the use of biosimilars in rheumatology and gastroenterology…
TOPLINE:Biomarker testing completion rates in patients with metastatic colorectal cancer (CRC) has increased over time in alignment with guidelines and…
In a recent Healio exclusive, Kelly Cushing-Damm, MD, MSCI, discussed emerging strategies for monitoring inflammatory bowel disease (IBD) that could…
A study presented at the Crohn’s & Colitis Congress revealed a significant increase in the cost of treating inflammatory bowel…